Trial intelligence / Profile preview

rhThrombin in Surgical Hemostasis

NCT04459871Phase 3Completed

Sponsor
Zelgen
Start
Nov 2019
Primary completion
Oct 2021
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 3 trial of Zepuning in postoperative hemorrhage, sponsored by Zelgen. Started Nov 2019; status: completed.

02

Drugs

Zepuning
03

Conditions

postoperative hemorrhage

Beyond the preview

Go deeper on NCT04459871.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04459871.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call